Achieved >90% accuracy for diagnosis of pneumonia and asthma vs...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 229 Last

Share
Profile

Follow
Tech goose

2,710 Posts.

506

04/08/17

01:58

Post #: 26281695
Share
Originally posted by whytee ↑

Look, if the patient is not very ill and you are differentiating an asthmatic cough in a known asthmatic (which would benefit from brochodilator therapy) from bacterial infection (which would benefit from antibiotics), sure. Perhaps there is an asthmatic with a mild attack (which can be brought on by a viral infection a well as environmental allergans) and doesn't need antiobiotics, then it might be reassuring and it might save admission and monitoring in hospital. That's certainly worthwhile and might reduce inappropriate antibiotic adminstration.

But the acoustic signature must necessarily include the effort of the patient and the type and location of any airway obstruction (be that internal to the airways from sputum or external due to compression or collapse). There are a myriad of causes that could generate the same physical conditions and a similar acoustic signature. Even MRI scans generate pictures with a "differential diagnosis" which needs to be correlated with other information in order to be confident of the diagnosis.

But the concept that its OK to diagnose and treat pneumonia using Resapp and a phoned prescription is a sure way for accusations of negligence followed by mal-practice suit and disciplinary proceedings.

Expand

Achieved >90% accuracy for diagnosis of

pneumonia and asthma vs pneumonia

Wish you'd read the presentation again..maybe even watch the YouTube attachments I sent??
RAP Price at posting: 31.0¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BUX

Buxton projects new graphite province discovery at WA Narryer play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 243 more messages in this thread...

First 229 Last

Add RAP (ASX) to my watchlist

Achieved >90% accuracy for diagnosis of pneumonia and asthma vs...

Top Stories

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News